Gratus Capital’s Axcelis ACLS Stock Holding History

Gratus Capital’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Hold	–	-$3.36M	–	323
2023 Q4	–	Hold	–	–	–	97
2023 Q3	–	Hold	–	–	–	80

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Gratus Capital's ACLS Position: Q1 2024 in Review

Gratus Capital sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 25,937 shares — an estimated $3.36M sold.

Gratus Capital first reported a position in ACLS in Q3 2023 and held it in 2 quarters. The position peaked at $4.23M in Q3 2023. 386 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

Gratus Capital reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
Gratus Capital sold 25,937 Axcelis shares in Q1 2024, an estimated $3.36M.
Gratus Capital first reported a position in Axcelis in Q3 2023 and held it in 2 quarters.
Gratus Capital's Axcelis position peaked at $4.23M in Q3 2023.
386 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Gratus Capital's 13F filing for Q1 2024, filed 13 May 2024.